FDA Recalls 465K Pacemakers Tied to MedSec Research

September 1, 2017


The United States Federal Drug Administration is recalling 465,000 pacemakers that attackers can gain unauthorized access to issue commands, change settings and maliciously disrupt. Affected are four models manufactured by Abbott Laboratories.

According to the FDA, the recalls of affected pacemakers are tied to research by MedSec Holdings that originally brought St. Jude Medical equipment flaws to light about a year ago. Abbott Laboratories acquired St. Jude Medical in January.

“Abbott has produced a firmware patch to help mitigate the identified vulnerabilities in their pacemakers that utilize radio frequency communications. A third-party security research firm has verified that the new firmware version mitigates the identified vulnerabilities,” according to a FDA.

Read More on Threat Post